Rein Therapeutics, Inc.
RNTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001420565
No open-market purchases or sales by Rein Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $42.3M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Rein Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- −1 vs. Q2 2023
- Shares held
- 1.05M
- +22.8K (+2.2%) vs. Q2 2023
- Total value
- $1.59M
- −$241.4K (−13.2%) vs. Q2 2023
- New holders
- 1
- 3 more added
- Sold out
- 2
- 2 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RNTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 59 | $42.3M |
| Q1 2026 | 46 | $14.8M |
| Q4 2025 | 48 | $12.5M |
| Q3 2025 | 40 | $9.76M |
| Q2 2025 | 36 | $9.30M |
| Q1 2025 | 39 | $10.6M |
| Q4 2024 | 31 | $13.1M |
| Q3 2024 | 32 | $16.3M |
| Q2 2024 | 29 | $13.5M |
| Q1 2024 | 23 | $11.0M |
| Q4 2023 | 20 | $3.24M |
| Q3 2023 | 16 | $1.59M |
| Q2 2023 | 17 | $1.83M |
| Q1 2023 | 19 | $1.30M |
| Q4 2022 | 19 | $3.21M |
| Q3 2022 | 33 | $5.86M |
| Q2 2022 | 37 | $8.34M |
| Q1 2022 | 42 | $16.5M |
| Q4 2021 | 43 | $18.9M |
| Q3 2021 | 43 | $33.6M |
| Q2 2021 | 47 | $41.5M |
| Q1 2021 | 52 | $48.0M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Rein Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Satter Management Co., L.P. | 830,466 | $1.26M | 2.16% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 56,513 | $85.3K | 0.00% | +1,467+2.7% | Added |
| Vanguard Group Inc | 39,934 | $60.7K | 0.00% | −539−1.3% | Reduced |
| Blair William & Co | 28,997 | $44.1K | 0.00% | −670−2.3% | Reduced |
| KCK Ltd. | 22,341 | $34.0K | 0.05% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 20,155 | $30.4K | 0.00% | +20,155 | New |
| HighTower Advisors, LLC | 19,204 | $29.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 18,964 | $29.0K | 0.00% | +3,100+19.5% | Added |
| Tower Research Capital LLC (TRC) | 4,509 | $6.85K | 0.00% | +767+20.5% | Added |
| JFS Wealth Advisors, LLC | 1,590 | $2.42K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 1,250 | $1.90K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,250 | $1.90K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 189 | $287 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 125 | $190 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 24 | $36 | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 17 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 0 | $0 | 0.00% | −1,357−100.0% | Sold out |
| ICA Group Wealth Management, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |